A Randomized Clinical Study Comparing a Fully-Coated Cementless Stem Versus a Cemented Stem for Total Hip Replacements
NCT ID: NCT00689689
Last Updated: 2012-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
48 participants
INTERVENTIONAL
1998-07-31
2009-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison of a Resurfacing Hip System to Standard Total Hip Arthroplasty
NCT00253877
Resurfacing Hemiarthoplasty Versus Conventional Stemmed Arthroplasty
NCT00664989
A Comparison of Two Type of Stems in Revision Hip Arthroplasty
NCT00253838
RCT Comparing Ion Levels and Clinical Outcomes of A-Class BFH to Metal on Polyethylene Total Hip Replacement
NCT00911599
An Assessment of 4 Different Bearing Types in Hip Replacement Types to Analsye the Lowest Wear Rates of Polyethylene
NCT03900039
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fully Coated Prodigy Stem (AML)
Total hip arthroplasty with fully coated prodigy stem (AML)
Fully coated Prodigy stem
Total hip arthroplasty with fully coated Prodigy stem
Cemented Endurance Hip Stem
Total hip arthroplasty with cemented Endurance hip stem component
Cemented Endurance Stem
total hip arthroplasty with cemented endurance stem
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fully coated Prodigy stem
Total hip arthroplasty with fully coated Prodigy stem
Cemented Endurance Stem
total hip arthroplasty with cemented endurance stem
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Revisions of failed osteotomies may be included
* Bone quality felt to be acceptable to the surgeon for cementless arthroplasty preoperatively in patients \> 72 years of age
Exclusion Criteria
* Revision cemented total hip replacement
* Charcot joints
* Patients with primary or secondary bone tumors in the vicinity of the joint to be replaced
* C.D.H. with abnormally placed acetabuli or femoral canals
* Fibromyalgia patients
72 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nova Scotia Health Authority
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ross K Leighton, MD, FRCS(C)
Role: PRINCIPAL_INVESTIGATOR
Capital Health, Canada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDHA-RL-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.